Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius Braun

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Alimentary Pharmacology & Therapeutics|January 29, 2022
Editorial: targeting aberrant hepatic inflammation for treatment of non-alcoholic steatohepatitis-authors' replyRifaat Safadi, Marius Braun, Adi Francis, et al.
Journal of Proteome Research|January 15, 2009
Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitisCuiying Chen, Hemda Schmilovitz-Weiss, Xue-en Liu, et al.
Transplantation|August 31, 2022
Urgent Liver Transplantation for Acute Liver Failure in Pregnant Women: The Optimum Timing for DeliveryPhilippe Ichai, Hanane Bouchghoul, Astrid Laurent-Bellue, et al.
Hepatology (Baltimore, Md.)|February 15, 2019
Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2)Markus Peck-Radosavljevic, Krzysztof Simon, Angelo Iacobellis, et al.
Journal of Crohn'S & Colitis|December 18, 2014
Prognosis of primary sclerosing cholangitis in israel is independent of coexisting inflammatory bowel DiseaseHenit Yanai, Shay Matalon, Amir Rosenblatt, et al.
Scientific Reports|October 21, 2020
Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot studyOhad Etzion, Harel Dahari, David Yardeni, et al.
BMC Infectious Diseases|March 1, 2018
Characterization of hepatitis B and delta coinfection in IsraelRachel Shirazi, Daniela Ram, Aviya Rakovsky, et al.
The Lancet. Diabetes & Endocrinology|November 18, 2024
Overweight and obesity among Israeli adolescents and the risk for serious morbidity in early young adulthood: a nationwide retrospective cohort studyYair Zloof, Maya Nitecki, Maya Simchoni, et al.
Antiviral Therapy|March 19, 2019
High frequency of multiclass HCV resistance-associated mutations in patients failing direct-acting antivirals: real-life dataYael Gozlan, Efrat Bucris, Rachel Shirazi, et al.
Antiviral Therapy|January 10, 2017
HCV genotype-1 subtypes and resistance-associated substitutions in drug-naive and in direct-acting antiviral treatment failure patientsYael Gozlan, Ziv Ben-Ari, Roy Moscona, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Alimentary Pharmacology & Therapeutics|January 29, 2022
Editorial: targeting aberrant hepatic inflammation for treatment of non-alcoholic steatohepatitis-authors' replyRifaat Safadi, Marius Braun, Adi Francis, et al.
Journal of Proteome Research|January 15, 2009
Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitisCuiying Chen, Hemda Schmilovitz-Weiss, Xue-en Liu, et al.
Transplantation|August 31, 2022
Urgent Liver Transplantation for Acute Liver Failure in Pregnant Women: The Optimum Timing for DeliveryPhilippe Ichai, Hanane Bouchghoul, Astrid Laurent-Bellue, et al.
Hepatology (Baltimore, Md.)|February 15, 2019
Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2)Markus Peck-Radosavljevic, Krzysztof Simon, Angelo Iacobellis, et al.
Journal of Crohn'S & Colitis|December 18, 2014
Prognosis of primary sclerosing cholangitis in israel is independent of coexisting inflammatory bowel DiseaseHenit Yanai, Shay Matalon, Amir Rosenblatt, et al.
Scientific Reports|October 21, 2020
Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot studyOhad Etzion, Harel Dahari, David Yardeni, et al.
BMC Infectious Diseases|March 1, 2018
Characterization of hepatitis B and delta coinfection in IsraelRachel Shirazi, Daniela Ram, Aviya Rakovsky, et al.
The Lancet. Diabetes & Endocrinology|November 18, 2024
Overweight and obesity among Israeli adolescents and the risk for serious morbidity in early young adulthood: a nationwide retrospective cohort studyYair Zloof, Maya Nitecki, Maya Simchoni, et al.
Antiviral Therapy|March 19, 2019
High frequency of multiclass HCV resistance-associated mutations in patients failing direct-acting antivirals: real-life dataYael Gozlan, Efrat Bucris, Rachel Shirazi, et al.
Antiviral Therapy|January 10, 2017
HCV genotype-1 subtypes and resistance-associated substitutions in drug-naive and in direct-acting antiviral treatment failure patientsYael Gozlan, Ziv Ben-Ari, Roy Moscona, et al.
Pageof 5